title: Inhaled corticosteroids, adrenal suppression and benign intracranial hypertension.
authors.affiliation: Blacktown-Mt Druitt Health, Sydney West Area Health Service, NSW, Australia. patrickho@ausdoctors.net
authors.forename: Patrick
authors.initials: P
authors.lastname: Patradoon-Ho
authors.forename: Hasantha
authors.initials: H
authors.lastname: Gunasekera
authors.forename: Monique M
authors.initials: MM
authors.lastname: Ryan
authors.forename: Geoffrey R
authors.initials: GR
authors.lastname: Ambler
mesh_terms: D000280:Administration, Inhalation; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects*; D000309:Adrenal Insufficiency / Q000139:chemically induced* / Q000150:complications; D000730:Androstadienes / Q000008:administration & dosage / Q000009:adverse effects; D015170:Cerebrospinal Fluid Pressure; D000068298:Fluticasone; D006261:Headache / Q000209:etiology* / Q000628:therapy; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D019586:Intracranial Hypertension / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D008279:Magnetic Resonance Imaging; D008297:Male; D013129:Spinal Puncture; D014057:Tomography, X-Ray Computed
chemical_list: D000305:Adrenal Cortex Hormones; D000730:Androstadienes; D000068298:Fluticasone; D006854:Hydrocortisone